National Evaluation System for health Technology Coordinating Center Expands Governing Committee into Digital Health

NESTcc Governing Committee adds digital health experts, enhancing focus on innovative technologies

ARLINGTON, Va.--(BUSINESS WIRE)-- The National Evaluation System for health Technology Coordinating Center (NESTcc), an initiative of the Medical Device Innovation Consortium (MDIC), today announced the addition of two new members to its Governing Committee: David Feygin, Ph.D., MBA, chief digital health officer and vice president of IT digital health at Boston Scientific, and David Rhew, M.D., chief medical officer and vice president of healthcare, Worldwide Commercial Business (WCB) at Microsoft.

The NESTcc Governing Committee is comprised of stakeholders from across the medical device ecosystem committed to the success of NESTcc. As the medical device and real-world evidence (RWE) ecosystem evolves to leverage digital health technologies, the NESTcc Governing Committee has selected Drs. Feygin and Rhew as representatives from the digital health stakeholder group to reflect innovative perspectives that are vital to the development and assessment of new technologies.

“From using artificial intelligence and machine learning for active surveillance to evaluating digital health tools for patient care, NESTcc is leading initiatives at the forefront of state-of-the-science, RWE clinical research for digital health technologies,” said Sandra Siami, MPH, senior vice president of NESTcc. “David Feygin and David Rhew are key opinion leaders and experts in their field, and we are thrilled to welcome them both to the NESTcc Governing Committee as we seek to expand NESTcc’s impact and reimagine the medical device regulatory paradigm.”

Dr. Feygin has led digital health organizations throughout his career, including establishing global efforts in the areas of advanced analytics, digital health transformation, and unified health IT infrastructure to improve patient safety and outcomes. He has developed digital applications that consider real-world utilization, leverage real-world and real-time data, and quickly iterate to ensure optimal care.

Dr. Rhew has been a driving force behind the development, validation, and deployment of digital health solutions recognized by global organizations as being some of the most innovative and impactful in the industry. A physician and computer scientist, Dr. Rhew is Chairman of the Consumer Technology Association’s Health Technology Division Board and faculty affiliate for the Center for Innovation in Global Health at Stanford University. Dr. Rhew has also served in key leadership roles at Samsung, Zynx Health Incorporated, the Division of Infectious Diseases at the VA Greater Los Angeles Healthcare System, and the National Quality Forum.

“Digital health tools are shaping the way care is delivered and the results we’re seeing in patient outcomes. The expertise and leadership of David Feygin and David Rhew are a welcome and exciting addition to the Governing Committee and will help inform NESTcc’s approach to guiding research at the edge of innovation,” said Adrian Hernandez, M.D., MHS, professor of Medicine at Duke School of Medicine, vice dean and executive director of the Duke Clinical Research Institute, and chair of the NESTcc Governing Committee.

About the National Evaluation System for health Technology Coordinating Center

In 2016, the U.S. Food and Drug Administration (FDA) awarded the Medical Device Innovation Consortium (MDIC) funding to establish the National Evaluation System for health Technology Coordinating Center (NESTcc). The Coordinating Center seeks to support the sustainable generation and use of timely, reliable, and cost-effective Real-World Evidence (RWE) throughout the medical device lifecycle, using high-quality Real-World Data (RWD) that meets robust methodological standards for the purpose of enhancing regulatory and clinical decision-making. For more information, visit http://www.nestcc.org.

About the Medical Device Innovation Consortium

Founded in 2012, the Medical Device Innovation Consortium (MDIC) is the first public-private partnership created with the sole objective of advancing medical device regulatory science throughout the total product life cycle. MDIC’s mission is to promote public health through science and technology and to enhance trust and confidence among stakeholders. MDIC works in the pre-competitive space to facilitate development of methods, tools, and approaches that enhance understanding and improve evaluation of product safety, quality, and effectiveness. Its initiatives improve product safety and patient access to cutting-edge medical technology while reducing cost and time to market. For more information, visit http://www.mdic.org.

Funding for NESTcc was made possible, in part, by the Food and Drug Administration through grant (3 U01 FD006292-03S1). Views expressed in written materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does any mention of trade names, commercial practices, or organization imply endorsement by the United States Government.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201210005885/en/